Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Alexandria Real Estate Equities, Inc.

ARENYSE
Wall Street Score · overall investment15/100
$40.60USD+$0.69 (+1.73%)
Company website www.are.com
Headquarters26 North Euclid Avenue, Pasadena, CA, 91101-6104, US
Financial statement currencyUSD · no FX conversion applied
Real Estate · REIT - Office
Price updated todayFinancials updated Oct 1, 2026

ARE · Price history

Price at last available close

$40.60

−$6.86 (-14.45%) 1M

2026-10-29

Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.

Company & revenue

About Alexandria Real Estate Equities, Inc.

Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.

Who they are

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® real estate investment trust, stands as the pioneering and most seasoned entity in the specialized domain of urban office properties. Since its inception in 1994, Alexandria has uniquely focused on the ownership, operation, and development of integrated campuses tailored for the life science, technology, and agtech sectors, strategically positioned within premier innovation ecosystems. By December 31, 2020, the company commanded a market capitalization of $31.

How they make money

Alexandria Real Estate Equities, Inc. operates as a real estate investment trust (REIT) that generates revenue primarily through the leasing of office and laboratory space to life science, agtech, and technology tenants. The company also derives income from providing strategic capital to life science companies through its venture capital platform and through the development and redevelopment of high-quality real estate assets.

Products & services

The company provides collaborative life science real estate, including office and laboratory space, and strategic venture capital investments in the life science sector.

Brands & revenue mix

No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.

Product / operating segments

No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.

Geographic revenue

No reconciled geographic revenue breakdown was confirmed for the current research period.

Customer types

Customer concentration

As of December 31, 2025, the company's tenant base is diverse, with no single tenant accounting for more than 5% of annual rental revenue.

Suppliers, materials & equipment

No supplier relationships were confirmed in the sources reviewed. This does not mean the company has no suppliers.

Competitors

  • BioMed Realty — A private real estate investment trust that focuses on life science real estate.Source
  • Healthpeak Properties, Inc. — A REIT that invests in real estate serving the healthcare industry, including life science properties.Source

Strengths

  • Long-tenured expertise in life science real estate nicheSource
  • Strategic locations in AAA life science innovation clustersSource

Risks

  • Concentration of properties in specific geographic life science clustersSource
  • Sensitivity to economic conditions affecting the life science and biotechnology industriesSource

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

15

Poor

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

18

Poor

Financial Strength

20

Business Quality / Moat

24

Management

0

Growth Quality

18

Risk / Durability

29

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

26

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

30/100

Building Historical Record

Model Score 30/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently cautious.

What we like
  • •Recent buyback activity is present
What to watch
  • •Elevated debt risk
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak
  • •Debt / balance-sheet profile needs attention

Company-specific research

Questions worth answering for ARE

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •What is driving ARE's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
  • •Is ARE's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •Is ARE's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • •What specifically needs to improve for ARE to reach sustainable profitability?
  • •What future growth or profitability would be needed to justify ARE's current valuation?
Elevated debt risk
Business analysis: 17 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

15

0–100 · Poor

Opportunity Score

26

0–100 · Poor

Market Cap

$7.07B

P/E Ratio

-8.5

EPS

$-5.57

52-Week High

$85.37

52-Week Low

$39.41

Beta

1.17

Analyst Target

$52.50

Shares Outstanding

170.4M

Total Revenue

$2.96B

Total Debt

$12.81B

Dividend Yield (TTM)

7.09%

View dividend history

Liquidation Value / Share

$112.48

Estimated net asset value per share

Dividend / Share (TTM)

$2.88

Trailing 12 months by ex-date; not a forecast

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
15/ 100
-11 pts / 5d

Strong downward momentum

5D -6.3% · 20D -13.7% · RSI 34 · Price vs 20D avg -6.2%
Volatility
35/ 100
+8 pts / 5d

Normal movement

20D realized vol 41.9% · 60D 43.0% · Acceleration 0.97x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for ARE

Detected from reported data — verify before acting.

Dividend history reported

Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.

Historical repurchase activity

Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.

Elevated debt risk

Total debt is at least one year of revenue • Interest coverage is below 2x • Cash covers less than 20% of total debt

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on ARE.

Potential upside factors

  • +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
  • +Long-tenured expertise in life science real estate niche.
  • +Strategic locations in AAA life science innovation clusters.
  • +Positive free cash flow may provide capacity to invest in growth.

Potential downside factors

  • −Debt risk (elevated): Total debt is at least one year of revenue.
  • −Interest coverage is below 2x.
  • −Cash covers less than 20% of total debt.
  • −Concentration of properties in specific geographic life science clusters.

These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Very Weak15/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Poor

15

Tap for breakdown →

Poor

30

Debt Cost1.8%
Debt Reduction YoY-0.1%
Debt / Equity0.82x

Tap for breakdown →

Poor

5

Revenue YoY-0.5%
Revenue CAGR2.2%
Net Margin-30.6%

Tap for breakdown →

Fair

55

Asset Growth YoY-9.2%
Liquidation/Share$112.48
Net Assets/MCap2.64x

Tap for breakdown →

Poor

5

Earnings Yield-10.9%
Buyback Yield0.8%
Debt Cost1.8%

Tap for breakdown →

Poor

0

ROIC-4.3%
ROE-5.8%
ROA-2.6%

Tap for breakdown →

Poor

24

EPS Growth—
FCF/Share Growth-0.1%
Rev/Share Growth2.6%

Tap for breakdown →

Poor

0

Intrinsic Value—
Value Reference—
MOS—

Tap for breakdown →

Poor

20

Revenue5
Moat24
Valuation0

Tap for breakdown →

Poor

0

MOS %—
Value Reference—
Deep Discount Reference—

Tap for breakdown →

Poor

14

Interest Coverage-5.3x
ROIC-4.3%
FCF Yield17.1%

Tap for breakdown →

Poor

10

Financial14
Valuation0
Debt30

Tap for breakdown →

Poor

26

Survival Years0.4 yrs
Current Ratio0.43x
FCF Margin47.6%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

6 historical score records available

Previous Score

15

Sep 8, 2026

Change

Unchanged

Current Score

15

Oct 1, 2026

Category Changes

Revenue+0.3
Debt0
Assets0
Capital0
Management0
Moat0
Valuation0
Buffett0

ARE score was unchanged.

Projected Score

Projected Score

11

Projected Change

-3.2 points

Preliminary comparable-period financial changes suggest decline of approximately 3.2 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Valuation unavailable

Current Price

$40.60

Model Intrinsic Value

—

Difference

—

Margin of Safety

—

Value Reference: —
Deep Discount Reference: —

Intrinsic value is not currently available for this stock, so valuation can't be calculated.

Financial Charts

Revenue

201420152016201720182019202020212022202320242025$0$800M$1.6B$2.4B$3.2B

Additional Metrics

Operating Cash Flow

201520172019202120232025$0$450M$900M$1.4B$1.8B

Total Debt

201520172019202120232025$0$3.5B$7.0B$10.5B$14.0B

Total Assets

201520172019202120232025$0$9.5B$19.0B$28.5B$38.0B

Net Margin %

No data
Monetary values in USD. Share counts in raw units.

Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.

Line ItemTTM2025202420232022202120202019201820172016
Revenue$2.96B$2.97B$3.05B$2.84B····························
Cost of Revenue$903.3M$922.6M$909.3M$859.2M····························
Gross Profit$2.05B$2.05B$2.14B$1.98B····························
Research & Development$0.00$0.00$0.00$0.00····························
SG&A Expenses$128.8M$117.0M$168.4M$199.4M····························
Operating Expenses$3.41B$3.25B$1.37B$1.29B····························
EBITDA$425.6M$360.4M$1.90B$1.45B····························
Operating Income-$1.35B-$1.20B$769.7M$690.4M····························
Interest Expense$249.5M$226.7M$185.8M$74.2M····························
Income Before Tax-$966.8M-$1.22B$510.7M$281.0M····························
Income Tax Expense$9.0M$0.00$0.00$0.00····························
Net Income-$904.0M-$1.43B$322.9M$103.6M····························
Basic EPS$-5.57$-8.44$1.80$0.54····························
Basic Shares188M170M172M171M····························
Diluted Shares188M170M172M171M····························
Upgrade to Premium for up to 10 annual periods, where available.
Upgrade to Premium

Earnings Summary

Estimated earnings date:A future estimated earnings date is not currently available.
Jun 30, 2026Q2FY2026

Revenue

$796.0M

Estimate unavailable.

Revenue Beat/Miss

Not available (no estimate stored)

EPS

$0.07

Estimate unavailable.

EPS Beat/Miss

Not available (no estimate stored)

Debt Change

-6.2%

Cash Change

-9.6%

Margin Change

+16.0 pp

Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.

Financial Changes Since Prior Period

What Improved

  • Margins expanded
  • Debt reduced

What Weakened

  • Cash position declined

Potential Score Impact

Positive indicators included revenue growth, debt levels, net income margin. Pressure indicators included EPS growth, cash levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.

Stored Earnings Analysis

Revenue increased 8.0%. EPS declined 110.3%. Cash declined 9.6%. Total debt declined 6.2%. Net income margin improved by 16.0 percentage points.

Earnings-Call Transcript

Earnings-call transcript analysis is not currently available.

These results may influence future scores when the next evaluation is completed.

Upgrade to Premium to unlock all earnings history.View plans
Earnings data: 122 days ago · Stale

Insider Activity

Guru / Smart Money

Guru Score

7

Smart Money

7

Number of Gurus

1

Total Guru Value

Avg Portfolio Weight

Largest Holder

Largest Holder %

New Positions

Increased Positions

Reduced Positions

Exited Positions

Net Guru Sentiment

Short Interest

Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.

Dividend History

Log in to view dividend history.

Conservative Projected Values

3 Years

$———.——

Premium

5 Years

$———.——

Premium

10 Years

$———.——

Premium

Conservative Projection Rate

——%

Premium

Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.

Conservative Projected Values

Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.

Start 7-Day Free Trial

Historical Outperformance Record

Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.

Start 7-Day Free Trial

Historical Trends

6 historical records
Jul 19, 26Jul 23, 26Aug 11, 26Sep 1, 26Sep 8, 26Oct 1, 260255075100

Historical Score Chart

3 of 6 records shown
3 historical score records are shown. Start your seven-day free trial to unlock 3 more records and the complete score history.Start Free Trial

Wall Street Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Debt Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Revenue Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Asset Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Capital Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Management Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Moat Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Valuation Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Buffett Score

Sep 1, 26Sep 8, 26Oct 1, 260255075100

Intrinsic Value

No data

Value Reference

No data

Margin of Safety %

No data

Related Companies

REIT - Office

PSTL

Postal Realty Trust, Inc.

28Poor
$21.57View

BXP

BXP, Inc.

28Poor
$63.02View

CDP

COPT Defense Properties

26Poor
$33.47View

KRC

Kilroy Realty Corporation

24Poor
$35.43View

NLOP

Net Lease Office Properties

24Poor
$9.20View

HIW

Highwoods Properties, Inc.

23Poor
$29.21View

News

Rumor Mill · ARE

Corporate developments & opportunities

Explore market →

No reviewed developments match this filter.

Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest growth stocksTop REITsHow Wall Street Score worksHow to analyze a stockUnderstanding financial healthIntrinsic value guide

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial